SEC Filing Update: #TCRX TScan Therapeutics, Inc. : $0.78

Sector: Healthcare | YTD: 🔽 -24.27% The SEC disclosed Today (14-AUG-2026) that Lynx1 Capital Management LP has INCREASED #TCRX Shares by 155.88% 🟢 * Previous Holdings: 8.02M Shares * Current Holdings: 20.52M Shares * Increase+12.50M * Increased(%)+155.88% * Ownership: 13.1% * Estimated Investment Value: $9.62M https://www.thinksabio.com/reports/isr/TCRX Institutional ownership in #TCRX has been steadily rising over the past 2 quarters in Shares: Q4 2025: 30.69M Q1 2026: 32.50M